Therapeutic drug monitoring market to reach $3.37 billion by 2024
“The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024. The growing need to perform drug profiling for various medications, such as anti-epileptics, immunosuppressants, and antibiotics, is one of the foremost factors responsible for the market growth�
The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.
Follow Us: